Fate Therapeutics Inc (NASDAQ: FATE) has decided to terminate the collaboration and option agreement with Janssen Biotech Inc, a Johnson & Johnson unit (NYSE: JNJ), on revised terms and conditions...
Tag: Janssen
Risk Of Covid Hospitalization 5 Times Higher With Johnson & Johnson Shot Than Pfizer
Topline Johnson & Johnson’s Covid-19 vaccine was far less effective at keeping people out of hospital than the Pfizer-BioNTech shot, according to a peer reviewed study published in JAMA Network Op...
Fate Therapeutics stocks heads for record selloff after Janssen collaboration terminated and job cuts
Shares of Fate Therapeutics Inc. FATE, -61.18% plunged 56.8% in premarket trading, putting them on track for a record one-day selloff, after the biopharmaceutical company announced the termination of ...